Ionis Pharmaceuticals(IONS) - 2023 Q3 - Quarterly Report
Ionis Pharmaceuticals(IONS)2023-11-02 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 (Exact name of Registrant as specified in its charter) Delaware 33-0336973 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 2855 Gazelle Court, Carlsbad, California 92010 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF SECU ...